Artigo Acesso aberto Produção Nacional Revisado por pares

Day–night pattern of autonomic nervous system modulation in patients with heart failure with and without sleep apnea

2009; Elsevier BV; Volume: 148; Issue: 1 Linguagem: Inglês

10.1016/j.ijcard.2009.10.023

ISSN

1874-1754

Autores

Linda Massako Ueno, Luciano F. Drager, Ana Clara Tude Rodrigues, Maria Urbana Pinto Brandão Rondon, Wilson Mathias, Eduardo Moacyr Krieger, Rubens Fazan, Carlos Eduardo Negrão, Geraldo Lorenzi‐Filho,

Tópico(s)

Cardiovascular Syncope and Autonomic Disorders

Resumo

IntroductionAmong patients with congestive heart failure (CHF) both obstructive and central sleep apnea (SA) are associated with increased sympathetic activity. However, the day–night pattern of cardiac autonomic nervous system modulation in CHF patients with and without sleep apnea is unknown.Material and methodsTwenty-five CHF patients underwent polysomnography with simultaneous beat-to-beat blood pressure (Portapres), respiration and electrocardiogram monitoring. Patients were divided according to the presence (SA, n=17) and absence of SA (NoSA, n=8). Power spectral analyses of heart rate variability (HRV) and spontaneous baroreflex sensitivity (BRS) were determined in periods with stable breathing while awake at 6 am, 10 am, 10 pm, as well as during stage 2 sleep. In addition, muscle sympathetic nerve activity (MSNA) was evaluated at 10 am.ResultsRR variance, low-frequency (LF), high-frequency (HF) powers of HRV, and BRS were significantly lower in patients with SA compared with NoSA in all periods. HF power, a marker of vagal activity, increased during sleep in patients with NoSA but in contrast did not change across the 24-hour period in patients with SA. MSNA was significantly higher in patients with SA compared with NoSA. RR variance, LF and HF powers correlated inversely with simultaneous MSNA (r=−0.64, −0.61, and −0.61 respectively; P<0.01).ConclusionsPatients with CHF and SA present a reduced and blunted cardiac autonomic modulation across the 24-hour period. These findings may help to explain the increased cardiovascular risk in patients with CHF and SA.

Referência(s)